Medallia Inc (MDLA)

33.99  +0.02 (+0.06%)

After market: 33.9999 +0.01 (+0.03%)

Fundamental Rating

3

Taking everything into account, MDLA scores 3 out of 10 in our fundamental rating. MDLA was compared to 277 industry peers in the Software industry. MDLA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, MDLA is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MDLA has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -14.41%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -34.44%
PM (TTM) -37.34%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

There is no outstanding debt for MDLA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

MDLA has an Altman-Z score of 2.71. This is not the best score and indicates that MDLA is in the grey zone with still only limited risk for bankruptcy at the moment.
MDLA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.71
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

MDLA has a Current Ratio of 1.84. This is a normal value and indicates that MDLA is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio N/A

More info and screens

6

3. Growth

3.1 Past

The earnings per share for MDLA have decreased strongly by -950.00% in the last year.
The Revenue has grown by 18.83% in the past year. This is quite good.
MDLA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.25% yearly.
EPS 1Y (TTM)-950%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1000%
Revenue 1Y (TTM)18.83%
Revenue growth 3Y22.25%
Revenue growth 5YN/A
Revenue growth Q2Q24.74%

3.2 Future

Based on estimates for the next years, MDLA will show a very strong growth in Earnings Per Share. The EPS will grow by 91.00% on average per year.
Based on estimates for the next years, MDLA will show a very strong growth in Revenue. The Revenue will grow by 20.67% on average per year.
EPS Next Y-682.76%
EPS Next 2Y-20.69%
EPS Next 3Y60.67%
EPS Next 5Y91%
Revenue Next Year20.49%
Revenue Next 2Y19.81%
Revenue Next 3Y21.03%
Revenue Next 5Y20.67%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDLA. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 1801.27, which means the current valuation is very expensive for MDLA.
MDLA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.31.
Industry RankSector Rank
PE N/A
Fwd PE 1801.27

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -49.39

4.3 Compensation for Growth

A more expensive valuation may be justified as MDLA's earnings are expected to grow with 60.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.69%
EPS Next 3Y60.67%

More info and screens

0

5. Dividend

5.1 Amount

MDLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Medallia Inc

NYSE:MDLA (10/28/2021, 7:53:36 PM)

After market: 33.9999 +0.01 (+0.03%)

33.99

+0.02 (+0.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.47B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1801.27
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.41%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -34.44%
PM (TTM) -37.34%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.84
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-950%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-682.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)18.83%
Revenue growth 3Y22.25%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y